![Medicinal Cannabis Draws Eyes as Oil Slides and Bond Yields Climb [FTSE AIM UK 50 INDEX]](https://cedclinic.com/wp-content/uploads/2026/06/ced-unsplash-ke6jYtwXDKA-1-150x150.jpg "Medicinal Cannabis Draws Eyes as Oil Slides and Bond Yields Climb [FTSE AIM UK 50 INDEX] 18")
This neuroimaging study of drug-free altered states provides mechanistic insights into consciousness modulation that may inform our understanding of how psychedelics work therapeutically. Understanding endogenous pathways to altered consciousness could help identify biomarkers for psychedelic response and potentially guide non-pharmacological interventions.
Researchers used fMRI to study a woman who can voluntarily enter trance-like states without substances, finding brain activity patterns that share similarities with psychedelic-induced states. The study identified specific neural network changes during these self-induced altered states, particularly involving default mode network modulation. While intriguing, this represents a single case study of an individual with unusual abilities, limiting generalizability to typical patients or therapeutic applications.
“This is fascinating neuroscience, but it’s one extraordinary individual — not a treatment pathway I can recommend to patients. What it does give us is a clearer picture of the brain mechanisms underlying altered states, which helps me understand what we’re actually targeting when we use psychedelic medicines therapeutically.”
💬 Join the Conversation
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- What is the clinical relevance rating of this psychedelics research?
- What therapeutic areas do psychedelics research typically focus on?
- Why are psychedelics considered noteworthy in clinical settings?
- What makes this psychedelics news particularly relevant for clinicians?
- How do psychedelics relate to neuroscience and consciousness research?
- Read next
FAQ
What is the clinical relevance rating of this psychedelics research?
This research has been assigned a CED Clinical Relevance rating of #70, indicating “Notable Clinical Interest.” This classification means the findings represent emerging developments or policy changes that warrant close monitoring by healthcare professionals.
What therapeutic areas do psychedelics research typically focus on?
Psychedelics research primarily focuses on mental health applications, neuroscience, and consciousness studies. These compounds are being investigated for their potential to treat various psychiatric conditions and expand our understanding of brain function.
Why are psychedelics considered noteworthy in clinical settings?
Psychedelics are gaining clinical attention due to their unique mechanisms of action on consciousness and neural pathways. They represent a potentially transformative approach to treating mental health conditions that have been resistant to traditional therapies.
What makes this psychedelics news particularly relevant for clinicians?
The classification as “Notable Clinical Interest” suggests this represents emerging findings or policy developments in the psychedelics field. Clinicians should monitor these developments as they may impact future treatment options and regulatory frameworks.
How do psychedelics relate to neuroscience and consciousness research?
Psychedelics offer unique insights into brain function and consciousness by temporarily altering neural connectivity patterns. This makes them valuable research tools for understanding both normal brain function and potential therapeutic mechanisms for mental health disorders.
